Forecast
Period
|
2026-2030
|
Market
Size (2024)
|
USD
3.82 Billion
|
Market
Size (2030)
|
USD
6.32 Billion
|
CAGR
(2025-2030)
|
8.72%
|
Fastest
Growing Segment
|
Portable
|
Largest
Market
|
North
America
|
Market Overview
The Oxygen Concentrators market was valued at USD 3.82 Billion in 2024 and is expected to reach USD 6.32 Billion by 2030 with a CAGR of 8.72%. A oxygen concentrators is a vital component of medical equipment
that provides support to patients with low blood oxygen levels. Its purpose is
to supply supplemental oxygen to patients, with a higher concentration than the
atmosphere. This device receives air, purifies it, and delivers it to the
patient. The operation of an oxygen concentrator is straightforward and easily
understood. oxygen concentrators offer convenience, portability, safety,
compactness, cost-effectiveness, and contribute to a reduced risk of heart
attacks and respiratory illnesses. Furthermore, they promote improved mental
clarity and overall mood.
Oxygen concentrators
enable patients to travel with ease due to their lightweight nature,
affordability, and enhanced efficacy. The significance of oxygen concentrators is
evident in the global market, reflecting the lifestyle of patients. These
devices are classified into continuous flow, pulse flow, and other types.
Continuous flow units continuously emit oxygen, even during inhalation and
exhalation. Pulse flow units detect inhalation and only deliver oxygen at that
specific moment. While pulse dosages are suitable for many individuals, they
may not be suitable for those with specific medical conditions.
For nocturnal or night
shifts, doctors often recommend continuous flow machines, while pulse dose
machines can be used throughout the day by many patients. Oxygen concentrators
are utilized by patients with pulmonary disorders such as bronchitis, respiratory
problems, lung cancer, and severe pneumonia. These devices can be used at home
and in healthcare settings to fulfill the oxygen requirements of patients.
Additionally, they are employed to generate oxygen-rich air in the atmosphere
by extracting surrounding air, compressing it, purifying it, and eliminating
nitrogen and other contaminants.
Key Market Drivers
Rising
Incidences of Respiratory Diseases
The growing number of
individuals diagnosed with respiratory diseases, such as lung cancer, chronic
obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and
influenza, highlights the urgent need for effective oxygen therapy solutions. Chronic respiratory diseases impact over 550 million adults globally and represent a leading cause of mortality and long-term disability. Pediatric populations are also significantly affected, with asthma identified as the most prevalent chronic condition among children, currently impacting approximately 14% of this demographic a figure that continues to grow. Over the past thirty years, the prevalence of chronic respiratory conditions has increased by an estimated 40%, underscoring a mounting public health challenge with substantial implications for healthcare systems worldwide. Oxygen
concentrators offer a breakthrough in medical technology by providing a
convenient and versatile option for delivering oxygen to patients. This
empowers individuals to manage their respiratory conditions more effectively,
ultimately enhancing their overall quality of life.
The rising incidences of
respiratory diseases have led to an increased demand for POCs in the healthcare
market. These innovative devices not only help patients receive the oxygen they
need outside of the hospital setting but also enable healthcare providers to
extend their care beyond traditional boundaries. By facilitating home-based
oxygen therapy, POCs reduce the burden on healthcare facilities, ensuring that
patients can receive continuous care in the comfort of their own homes.
In addition to the
numerous benefits for patients and healthcare providers, POCs also present a
cost-effective solution. Unlike traditional oxygen therapy methods, which often
require frequent cylinder refills or maintenance of stationary concentrators, POCs
eliminate these inconveniences. This not only saves time and resources but also
ensures a seamless and uninterrupted oxygen supply for patients, leading to
improved treatment outcomes.
With their portability,
convenience, and cost-effectiveness, POCs are revolutionizing the field of
respiratory care. By meeting the demand for effective oxygen therapy solutions,
POCs are making a significant impact on the lives of individuals with respiratory
diseases, offering them newfound freedom, independence, and improved
well-being.
Growing
Preference for Home-Based Medical Care
Home-based medical care
has emerged as a crucial aspect of modern healthcare, emphasizing the
importance of oxygen concentrators that empower patients to receive treatment
in the comfort of their own homes, without the need for hospitalization or
frequent visits to clinics. In this context, oxygen concentrators have gained
significant traction as a convenient and lightweight solution for delivering
oxygen therapy to patients at home. The growing preference for home-based care
has consequently led to a surge in the demand for POCs, as they offer a
practical and efficient means of administering oxygen therapy outside of
traditional healthcare settings.
Beyond the convenience and
portability, they provide, POCs also hold the potential for substantial cost
savings within healthcare systems. By enabling patients to receive oxygen
therapy at home, POCs have the potential to reduce hospital stays,
readmissions, and visits to emergency departments, thereby optimizing the
allocation of healthcare resources. This cost-effectiveness is a key driving
factor behind the integration of POCs into home-based care strategies, as
healthcare providers recognize the value of leveraging these devices to enhance
patient care and improve overall healthcare outcomes.
The emphasis on home-based
medical care has underscored the need for portable medical devices,
particularly POCs, that empower patients to receive treatment conveniently and
effectively in their own homes. With their lightweight design and ability to
deliver oxygen therapy outside of hospitals and clinics, POCs have become an
indispensable tool in home-based care, offering not only enhanced patient
comfort but also cost savings and resource optimization within healthcare
systems.
Increasing
Geriatric Population
The market is being driven
by the aging population, which is prone to these ailments, as well as the
growing demand for practical portable technology. The global population aged 60 and above is projected to rise from 1.1 billion in 2023 to 1.4 billion by 2030, with the most pronounced growth occurring in developing regions. This accelerated demographic shift presents critical challenges and opportunities for public health systems, necessitating strategic planning to address the increased demand for age-related healthcare services and chronic disease management. The market for oxygen concentrators
will also be significantly affected by the increase in everyday exposure to
environmental pollutants. Increasing urbanization and
discretionary economic levels are the primary drivers fueling the expansion of
the oxygen concentrators industry. Urbanization continues to be a dominant global trend, with 55% of the world’s population currently residing in urban centers. This urban share is projected to increase to 68% by 2050, driving substantial shifts in infrastructure demand, healthcare delivery models, and resource allocation across metropolitan regions. Moreover, the increasing healthcare
expenditures and evolving lifestyles of individuals are two other significant
market factors that will further propel the market for oxygen concentrators.
As individuals age, their
susceptibility to respiratory conditions such as chronic obstructive pulmonary
disease (COPD), pneumonia, and other lung-related ailments increases. These
conditions often necessitate long-term oxygen therapy to effectively manage
symptoms and enhance the overall quality of life. Consequently, the growing
geriatric population directly contributes to the heightened prevalence of
respiratory diseases, resulting in an increased demand for oxygen concentrators
as an indispensable medical device for oxygen therapy.
In addition to their
medical importance, POCs offer the necessary mobility and portability that
enable the elderly population to maintain an active lifestyle while receiving
the vital oxygen support, they require. The desire for active aging among the
geriatric population significantly drives the demand for POCs, as these devices
empower them to fully engage in their desired activities, promoting
independence and overall well-being. By providing a seamless integration of
oxygen therapy into their daily routines, POCs play a crucial role in
facilitating an enhanced quality of life for the aging population.
Rise in
Advanced Technologies
Manufacturers' use of advanced technologies in
the production of oxygen concentrators is also driving market growth. By
leveraging cutting-edge innovations, companies are able to develop oxygen
concentrators with higher efficacy and lower costs, meeting the growing demand
for oxygen concentrators. The market
growth is fueled by investment funding and the implementation of appropriate
reimbursement policies by both the government and private institutions. These
initiatives provide a favorable environment for manufacturers to invest in research
and development, leading to the creation of innovative and high-quality oxygen
concentrators. Moreover, strategic activities such as mergers and acquisitions
among organizations not only encourage collaboration but also create platforms
for new market participants to enter and thrive in the industry.
In addition to these
factors, the market expansion is expected to be driven by firms increasing
their expenditure in the manufacturing of transportable pulse and
continuous-flow oxygen concentrators. As the demand for oxygen concentrators continues
to rise, manufacturers are investing more resources into developing and
producing reliable and efficient devices. This trend is expected to contribute
significantly to the overall growth and development of the market. Overall, the
combination of advanced technologies, investment funding, reimbursement
policies, and strategic activities is propelling the growth of the oxygen
concentrator market. With continuous advancements and a focus on meeting the
evolving needs of consumers, the market is poised for further expansion in the
coming years.
.webp)
Download Free Sample Report
Key Market Challenges
Stringent
Government Rules
The expansion of the
medical device sector is being hindered by recent modifications to the FDA's
approval process in several nations. These changes, which aim to ensure patient
safety and product efficacy, have introduced additional complexities and hurdles
that companies must navigate. As a result, the process of bringing innovative
medical devices to market has become more challenging and time-consuming.
Moreover, the industry is
not only grappling with regulatory obstacles but also facing a shortage of
skilled specialists. The demand for experts in medical device development,
manufacturing, and regulatory affairs far exceeds the available talent pool. This
scarcity of skilled professionals further exacerbates the difficulties faced by
companies in bringing their products to market efficiently. In addition, the
limited understanding of advanced medical technologies among healthcare
professionals and the general public poses a potential detriment to the
industry's growth. It is crucial for both healthcare providers and patients to
stay informed and educated about the latest advancements in medical devices to
ensure their effective utilization and widespread adoption. The medical device
sector is navigating through a complex landscape, with regulatory changes,
talent shortages, and knowledge gaps posing significant challenges. Addressing
these issues will be vital for the industry's sustained growth and the timely
availability of innovative medical technologies to benefit patients worldwide.
Reimbursement
Procedures
The expensive price of the
product is one of the main obstacles that hinders the widespread use of oxygen concentrators.
In emerging economies, where disposable cash is limited and the price of the
product is higher compared to wealthier nations, the acceptance of oxygen concentrators
is significantly restricted. Furthermore, the market expansion for these oxygen
concentrators is facing additional challenges due to the president's stringent
restrictions and reimbursement guidelines, which further impede their adoption
and growth. As a result, many individuals in these emerging economies are
unable to afford oxygen concentrators, which limits their access to this
important technology. The high cost not only affects individual consumers, but
also restricts the adoption of oxygen concentrators in industries and
communities that could greatly benefit from their use.
Moreover, the stringent
restrictions and reimbursement guidelines imposed by the president have created
a regulatory environment that is unfavorable for the growth of the oxygen concentrators
market. This not only discourages potential buyers, but also adds complexity
and uncertainty for manufacturers and distributors. In order to overcome these
challenges and promote the widespread use of oxygen concentrators, it is
crucial to address the affordability issue by exploring cost reduction
strategies and alternative financing options. Additionally, advocacy efforts
and engagement with policymakers can help create a more favorable regulatory
environment that encourages the adoption and growth of these oxygen concentrators.
By addressing these
factors and working towards making oxygen concentrators more accessible and
affordable, we can overcome the barriers that hinder their widespread use and
unlock their potential to improve safety and efficiency in various industries
and communities.
Key Market Trends
Increasing
Prevalence of Chronic Respiratory Diseases
The global market for
oxygen concentrators is experiencing significant growth due to the increasing
number of patients in need. According to the World Health Organization, chronic
obstructive lung disease (COPD) ranks as the third leading cause of death,
responsible for 3.23 million fatalities. Research indicates a rising prevalence
of respiratory conditions, necessitating the use of oxygen for breathing.
Furthermore, the market's expansion is fueled by the demand for long-term
oxygen therapy (LTOT) and the growing number of asthma patients. In order to
meet the needs of all patients requiring oxygen concentrators, there is an
emphasis on providing accessible and affordable solutions, supported by
favorable government initiatives. These factors together are driving the
expansion of the market for oxygen concentrators, ensuring that patients
receive the vital support they need for improved quality of life.
Continuous
New Product Launches
The increasing adoption of
oxygen concentrators in developing countries, driven by rising incomes and
advancements in technology, is expected to create significant opportunities for
the oxygen concentrators market during the forecast period. With the global
prevalence of chronic obstructive pulmonary disease (COPD) on the rise,
particularly in countries like India and China, the demand for oxygen concentrators
is projected to soar. This growing demand is further bolstered by companies'
heightened investment in the production of continuous flow oxygen concentrators
and pulse flow oxygen concentrators, which will fuel market growth in the
coming years. As the need for respiratory support continues to increase, the oxygen
concentrators market is poised for substantial expansion, offering a promising
outlook for both manufacturers and patients alike.
Segmental Insights
Type Insights
Based on their type, Portable segment emerges as the fastest growing segment in the Global Global Oxygen Concentrators Market. Globally, healthcare systems are increasingly shifting from hospital-centric models to more cost-effective home and outpatient care solutions. Portable oxygen concentrators (POCs) cater precisely to this trend, enabling patients especially those with chronic respiratory illnesses to maintain oxygen therapy while staying at home or moving freely in public settings. This flexibility significantly enhances quality of life and reduces hospitalization costs, making POCs an attractive option for both providers and patients.
Today’s oxygen therapy users, particularly in developed economies, prioritize convenience, autonomy, and mobility. Portable oxygen concentrators are lightweight, compact, and battery-operated, allowing users to travel, work, and socialize without interruption. The rising demand from active elderly populations and younger patients with chronic respiratory disorders has accelerated the adoption of portable units over traditional stationary systems. Ongoing innovations in miniaturization, battery life extension, and noise reduction have transformed POCs into efficient, user-friendly devices. Leading manufacturers are investing heavily in R&D to develop next-generation units that deliver reliable oxygen output with lower weight and longer operational time. The market has responded positively to these improvements, pushing growth within the portable segment.
Technology Insights
Based on the technology, the continuous flow segment
dominates the Global Global Oxygen Concentrators Market. Continuous flow oxygen concentrators are designed to deliver a constant, uninterrupted stream of oxygen typically measured in liters per minute (LPM) regardless of the patient’s breathing pattern. This feature is critical for patients with severe respiratory conditions such as COPD, pulmonary fibrosis, or late-stage chronic illnesses, where consistent oxygen saturation levels must be maintained. As such, clinicians and respiratory therapists frequently recommend continuous flow units for more complex cases, reinforcing demand for this technology.
Unlike pulse dose systems, which are more suitable for intermittent use, continuous flow concentrators are preferred in hospital, ICU, and long-term care settings where patients require around-the-clock oxygen support. The reliability of continuous delivery makes these units integral to clinical environments, particularly in acute and post-acute care, contributing significantly to the segment’s market share. Continuous flow concentrators are often required for use in conjunction with other medical devices such as CPAP machines, ventilators, and humidifiers. This interoperability is a key differentiator, especially for patients undergoing multi-modal respiratory therapy. Pulse dose systems generally cannot provide the volume or flow consistency needed for such integrations, making continuous flow technology the standard choice in complex treatment scenarios.
.webp)
Download Free Sample Report
Regional Insights
Based on region, North America region emerges as the largest market in the Global Oxygen Concentrators Market. North America, particularly the United States and Canada, is home to some of the most advanced healthcare systems in the world. The region boasts well-established hospitals, diagnostic centers, and home healthcare services. These systems are highly equipped to adopt and integrate advanced medical technologies such as oxygen concentrators, both in clinical settings and for home use.
The region has a significant prevalence of respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and sleep apnea, particularly among the aging population. According to the CDC, millions of Americans are affected by these disorders, which creates a sustained demand for supplemental oxygen therapy. Oxygen concentrators are a primary non-invasive solution for long-term oxygen therapy (LTOT), thereby driving market growth. North America is undergoing a pronounced demographic shift, driven by rising life expectancy and sustained declines in birth rates. This aging trajectory is expected to intensify in the coming decades, with a marked expansion in the 60+ age segment. By 2030, approximately 20% of the U.S. population will be aged 65 and above, reflecting a substantial shift in the region’s age structure. This demographic transformation is not only reshaping healthcare demand but is also directly influencing the long-term growth outlook for age-dependent medical technologies, including oxygen concentrators.
The Asia Pacific market is
expected to witness significant growth throughout the forecast period, driven
by factors such as rising disposable income, increasing tobacco consumption,
growing COPD patient population, improved healthcare infrastructure, heightened
awareness and acceptance of advanced oxygen concentrators, and expanding aging
population. Furthermore, the increasing number of elderly individuals in the
Asia Pacific region is poised to propel the oxygen concentrators industry in
the near future.
Recent Developments
- In Janury 2025, Caire has introduced the IntenOxy 5, a new stationary oxygen concentrator, to the HME/DME market in the United States and Puerto Rico. The company has strategically positioned the IntenOxy 5 for distribution through home medical equipment and durable medical equipment providers, with a planned market expansion into Canada in the near term.
- In October 2024, Inogen, Inc., a leader in medical technology specializing in home respiratory solutions, today announced the commercial launch of its Inogen® Rove 4™ Portable Oxygen Concentrator across the U.S. market. This strategic release reinforces Inogen’s commitment to expanding its portfolio of innovative, patient-centric oxygen therapy devices for the homecare sector.
- In March 2024, Drive DeVilbiss Healthcare and Sanrai International have jointly launched the PulmO2 10L Oxygen Concentrator, a next-generation device engineered for global clinical application. Developed through a strategic partnership, the PulmO2 combines energy efficiency and robust performance tailored to meet the demands of diverse healthcare settings. The product’s development and launch received backing from the UK government’s Foreign, Commonwealth, and Development Office (FCDO), underscoring its significance in advancing international medical technology.
Key Market Players
- Koninklijke
Philips N.V.
- Invacare Corporation
- Teijin Limited
- Precision Medical, Inc.
- Drive DeVilbiss Healthcare LLC
- Nidek Medical Products Inc.
- Inogen Inc.
- NGK Spark Plug Co., Ltd.
- GCE Group
- Linde Healthcare
By Type
|
By Technology
|
By Flowrate
|
By Application
|
By End
User
|
By Region
|
|
- Continuous Flow
- Pulse Flow
- Continuous/Pulse Flow
|
- 0-5l/min
- 5-10l/min
- Above 10l/min
|
- COPD
- Lung Cancer
- Pneumonia
- COVID-19
- Others
|
- Hospitals & Clinics
- Ambulatory Care Centers
- Home Care
- Others
|
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
|
Report
Scope:
In this report, the Global
Oxygen Concentrators Market has been segmented into the following categories,
in addition to the industry trends which have also been detailed below:
- Oxygen Concentrators Market, By Type:
o
Portable
o
Stationary
- Oxygen Concentrators Market, By Technology:
o
Continuous Flow
o
Pulse Flow
o
Continuous/Pulse Flow
- Oxygen Concentrators Market, By Flow Rate:
o
0-5l/min
o
5-10l/min
o
Above 10l/min
- Oxygen Concentrators Market, By Application:
o
COPD
o
Lung Cancer
o
Pneumonia
o
COVID-19
o
Others
- Oxygen Concentrators Market, By End User:
o
Hospitals &
Clinics
o
Ambulatory Care
Centres
o
Home Care
o
Others
- Oxygen Concentrators Market, By Region:
o North
America
§ United
States
§ Canada
§ Mexico
o Europe
§ France
§ United
Kingdom
§ Italy
§ Germany
§ Spain
o Asia-Pacific
§ China
§ India
§ Japan
§ Australia
§ South
Korea
o South
America
§ Brazil
§ Argentina
§ Colombia
o Middle
East & Africa
§ South Africa
§ Saudi
Arabia
§ UAE
Competitive
Landscape
Company
Profiles: Detailed analysis of the major companies present in
the Global Oxygen Concentrators Market.
Available
Customizations:
Global Oxygen
Concentrators market report with the given market data, Tech Sci
Research offers customizations according to a company's specific needs. The
following customization options are available for the report:
Company
Information
- Detailed
analysis and profiling of additional market players (up to five).
Global Oxygen
Concentrators Market is an upcoming report to be released soon. If you wish an
early delivery of this report or want to confirm the date of release, please
contact us at sales@techsciresearch.com